SAN DIEGO – ResMed Inc revenue for the quarter ended June 30, 2017, was $556.7 million, a 7% increase compared to the same period last year. Excluding the contribution from the Brightree business acquired in April 2016, revenue for the quarter was $520.5 million, a 6% increase.
“We finished the year with solid constant currency revenue growth, fuelled by sales of our devices, masks, and software-as-a-service revenue from Brightree,” said Mick Farrell, CEO of ResMed (Booth #1011 at Medtrade, scheduled for Oct 23-25 at the Georgia World Congress Center in Atlanta). “During the quarter, we made two acquisitions to augment our Brightree solutions, we presented and published results from clinical studies in sleep and COPD, and we launched two new products: AirTouch – the softest CPAP mask from ResMed; and AirMini – the world’s smallest CPAP.”
Farrell concluded, “Our board of directors has declared a 6% increase in our dividend this quarter, reflecting confidence in our long-term outlook and 2020 strategy. We are positioned for another great year ahead, as we deliver products and solutions that improve patient outcomes, create efficiencies for our customers, lower overall healthcare system costs and deliver cash to our shareholders.”